 | Up a level |
Number of items: 2.
Tezera, Liku B, Bielecka, Magdalena K, Ogongo, Paul, Walker, Naomi F, Ellis, Matthew, Garay-Baquero, Diana J, Thomas, Kristian, Reichmann, Michaels T, Johnston, David A, Wilkinson, Katalin Andrea et al (show 9 more authors)
(2020)
Anti-PD-1 immunotherapy leads to tuberculosis reactivation via dysregulation of TNF-α.
ELIFE, 9.
e52668-.
Eschweiler, Simon, Wang, Alice, Ramirez-Suastegui, Ciro, von Witzleben, Adrian, Li, Yingcong, Chee, Serena J, Simon, Hayley, Mondal, Monalisa, Ellis, Matthew, Thomas, Gareth J et al (show 3 more authors)
(2023)
JAML immunotherapy targets recently activated tumor CD8<SUP>+</SUP> T cells.
CELL REPORTS, 42 (2).
112040-.